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Background: Level of fatigue is related to the metabolic energy available to tissues
and cells, mainly through mitochondrial respiration, as well fatigue is the most common
symptom of poorly functioning mitochondria. Hence, dysfunction of these organelles
may be the cause of the fatigue seen in Chronic fatigue (CF). Placenta has been used
for treatment of fatigue and various disease, moreover peptides has known protect
mitochondrial viability, and alleviate fatigue. These properties of placenta and peptides
may link with its effect on mitochondria; therefore, it is highly important to investigate the
effectiveness of placenta peptide on fatigue and mitochondrial dysfunction.
Methods: After administration of sheep placenta peptide (SPP) for 1 month, mice’s were
forced to swim till exhaustion for 90 min to induce chronic fatigue. Electron microscopic
examination of skeletal muscle mitochondrial structure, tissue Malondialdehyde (MDA),
mitochondrial SOD and serum inflammatory cytokines level were investigated in order
to determine the potential effect of SPP on mitochondria during CF. Rat skeletal muscle
(L6 cell) were also treated with different concentration of SPP to determine the effect of
SPP on cell viability using Thiazoyl blue tetrazolium assay.
Results: Our finding revealed that forced swimming induced fatigue model can
cause mitochondrial damage through Reactive oxygen species (ROS) mediated
lipid peroxidation and Tumor Necrosis factor alpha (TNF-α) elevation. Whereas SPP
protected fatigue induced mitochondrial dysfunction through preventing ROS and TNF-
α generation, by maintaining mitochondrial dynamic network and by increasing serum
IL-6 level.
Conclusion: SPP can protect damage in mitochondrial components which will allow
proper functioning of mitochondria that will in turn inhibit progression of chronic
fatigue. Therefore, SPP may represent a novel therapeutic advantage for preventing
mitochondrial dysfunction in patients with chronic fatigue.
Keywords: chronic fatigue, mitochondria, placenta peptide, ROS, cytokines
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INTRODUCTION
Chronic fatigue is a clinically defined condition characterized by
persistent, severe, disabling fatigue lasting more than 6 months
that is not reversed by sleep or rest (Fukuda et al., 1994; Norheim
et al., 2011).
It is also an important secondary condition in many clinical
diagnoses and occurs naturally during aging. Fatigue is a
complex phenomenon determined by several factors, including
psychological health but at the biochemical level fatigue is
related to the metabolic energy available to tissues and cells,
mainly through mitochondrial electron transport (Chazotte,
2001; Finsterer, 2012). Fatigue is the most common symptom
of poorly functioning mitochondria; the classic symptoms of
persistent and debilitating fatigue, chronic muscle weakness,
and myalgia are consistent with mitochondrial dysfunction in
other diseases of known mitochondrial etiology (Chazotte, 2001;
Nicolson and Ellithorpe, 2006). Most fatigue patients report
mental concentration impairment and cognitive deficits, which
are also seen in mitochondrial dysfunctions (Nicolson and
Ellithorpe, 2006). Thus the integrity of mitochondrial is critical
to cell function and energy metabolism.
Even though fatigue decreases the quality of life in people
there are only few pharmacological drugs or therapies available
for the treatment of fatigue (Fukuda et al., 1994; Kim et al.,
2005; Reeves et al., 2007; Uthayathas et al., 2007). It has been
showed that, placenta has protective effect on chronic fatigue,
and many other diseases (Biswas et al., 2001; Kong et al., 2008;
Rozanova et al., 2012). Moreover, peptides protect mitochondrial
viability, and minimize further ROS generation (You et al., 2011).
These properties of placenta and peptides may link with its effect
on mitochondria; therefore it is highly important to investigate
the effectiveness of this drug on fatigue and mitochondrial
dysfunction.
The aim of this study was, to evaluate the potential effect of
SPP on mitochondrial dysfunction in forced swimming induced
fatigue model as well, to distinguish the underlying mechanism
by assessing mitochondrial structure and functioning through
ultra structural analysis of skeletal muscle mitochondria, ROS
and pro-inflammatory cytokines determination and investigating
SPP effect on cell viability.
MATERIALS AND METHODS
Reagent and Chemicals
Coenzyme Q10 powder from Sangon (Sangon biotech, Shang
Hai, China). Essential Medium Alpha (α MEM), Fetal bovine
serum (FBS) and Penicillin/streptomycin (P/S) from Hyclone
(Thermo Scientific Hyclone, US), Non-essential amino acid
Abbreviations: CF, Chronic fatigue; CoQ10, Coenzyme Q10; ETC, Electron
transport chain; FADH, Flavin adenine dinucleotide; H2O2, Hydrogen peroxide;
HO−, Hydroxyl radical; MDA, Malondialdehyde; MnSOD, Manganese Super
oxide dismutase; MTT, Thiazoyl blue tetrazolium; NADH, Nicotinamide-adenine
dinucleotide; ROS, Reactive oxygen species; SPP, Sheep placenta peptide; TBA,
Thiobarbituric acid; TNF-α, Tumor Necrosis factor alpha; TUTCM, Tianjin
University of Traditional Chinese Medicine.
(NEAA) from Gibco (life technologies, Grand Island, NY, USA),
ELISA kit for IL- 6 and TNF-α determination from xiao deng
(xiao deng, china), mtSOD and tissue MDA determination
kit from Cominbio (Suzhou Comin Biotechnology, Zhang Su,
China) were used in the study. All medium, chemical, and kits
used compiled with the required standard and were of analytical
grade.
Sheep Placenta Peptide Preparation
SPP was prepared and supplied by Tianjin jiani (Tianjin jiani
Biological Science and Technology Co., LTD, Tianjin, China.).
SPP was extracted by enzyme hydrolysis method, briefly fresh
sheep placenta washed, cut into small pieces and suspended with
appropriate amount of distilled water and then homogenized by
using a basic homogenizer. The homogenate was heated at 90◦C
for 15 for 15 min. After heating the tissue homogenate hydrolyzed
with protease and Flavourzyme followed by cultivating with dry
yeast at 35◦C for 60 min and heat inactivating at 95◦C for 10 min.
the supernatant was collected by centrifugation and lyophilized
to obtain the powder form. The total nitrogen and polypeptide
contents and molecular mass of SPP was determined using gel
filtration chromatography as describe by Jiang TC et.al (Jiang
et al., 2014).
Animals
Male Kunming mice weighting 21–27 g were housed under
standard laboratory conditions, provided with standard diet
and drinking water ad libitum. Animal experiments were
approved by TUTCM Ethical Review Committee and carried
out in accordance with international guidelines for care and
use of laboratory animals. After 1 week of acclimatization
the mice were randomly divide in to five groups, 10 mice
in each group as follow; normal control (mice without drug
and without forced swimming), model (mice without drug but
with forced swimming), SPP-200 (mice taking 200 mg/kg SPP
and with forced swimming), SPP-400 (mice taking 400 mg/kg
SPP and with forced swimming), positive control (mice taking
200 mg/kg CoQ10 and with forced swimming). SPP was dissolved
with 0.5 ml of normal saline, orally given via gavage daily
for 1 month, normal control and model groups were only
administered normal saline as a vehicle. Swim screening were
undergone two times to eliminate the mice which unable
to swim.
Forced Swimming Test
After administration of the drug for 1 month and after 30 min
of the last intragastric administration, 10 mice were taken from
each group and placed individually in to a plastic swimming
pool containing 30–40 cm deep water with the temperature
maintained at 30 ± 2◦C. The mice were forced to swim till
exhaustion for 90 min. After 1 h rest all animal were anesthetized
with 10% chloral hydrate and blood were collected from eye ball.
Serum was extracted and stored at−80◦C and red gastrocnemius
muscle was collected from the hind limbs. Aliquots of each
sample were quickly snap freezed in liquid nitrogen and stored
at−80◦C for further analysis until required.
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Electron Microscopic Examination of
Mitochondrial Structure
Small pieces of fresh skeletal muscle (∼1 mm) from mice
hind limb were fixed with 6% glutaraldehyde, 6% valeric
aldehyde fixatives then post fixed with 1% osmium tetroxide,
dehydrated, and embedded in EPON. Ultrathin (500 nm)
longitudinal and transverse sections were cut for each sample
using ultra-thin slicing machine (LEICA-EM UC7, Germany).
The sections stained with lead citrate and uranyl acetate.
Longitudinal and transverse sections of the specimen were
examined using transmission electron microscopy (H600
Hitachi). Microphotographs were randomly taken from each
block then mitochondrial morphology and structure were
analyzed.
Tissue MDA and Mitochondrial SOD
(MnSOD) determination
Mice skeletal muscle MDA was determined to quantify lipid
peroxidation by measuring reaction of tissue MDA with TBA
to form blue colored formazan in presence of phenazine metha
sulphate (PMS) and NADH using microplate reader (thermo
scientific Varioskan).
For determination of mitochondrial SOD level, mitochondria
were isolated from muscle homogenates by differential
centrifugation based on manufacturer kits protocol. Briefly
skeletal muscle from mice hind limb were excised and
homogenized with appropriate medium. The homogenates
were centrifuged at 600 g for 5 min to remove cell debris and the
nuclear fraction. And the resultant supernatant was centrifuged
at 10,000 g for 10 min to sediment mitochondria. Mitochondrial
sediment was ultra-sonicated (at 20% power, 3 s, Interval of 10 s,
30 times). Protein was estimated and pellets were suspended in
appropriate buffer solution. Measurement of mice mitochondrial
SOD level was estimated by following reduction of nitroblue
tetrazolium (NBT) using microplate reader.
Inflammatory Cytokines Level
Determination
A Quantitative analysis of serum TNF-α and IL-6 level were
measured based on standard sandwich enzyme-linked immune-
sorbent assay technology. The absorbance of yellow color was
detected at 450 nm using microplate reader.
Cell Viability Assay
Over all cell viability of SPP was measured by MTT assay as
follow; L6 cell were seeded into 96 well culture plates at a density
of 3 × 104 cells per well and in α-MEM medium supplemented
with 10% FBS 1% NEAA and 1% P/S, incubated for 24 h.
After adherence for 24 h, the cell were exposed to different
concentrations of SPP (50, 100, 500 ng/ml, 1, 2, 4, 6, 8, 10, 15, 25,
50, 75, 100, 200, 400, 600, 800 µg/ml, 1 mg/ml) and incubated for
additional 24 h. After incubation, the assay media was replaced
with 10 ul of MTT solution. 5 mg/ml final concentration of MTT
was added to each well and the cells were allowed to incubate
at 37◦C for an additional 4 h. The media was removed, and the
resulting formazan crystals were solubilized in in 100 ul DMSO.
The absorbance was measured at 570 nm using microplate reader.
The number of living cells in the treated groups was expressed as a
percentage of the control group; (absorbance of drug/absorbance
of control)× 100. All assays were performed with triplicates.
Statistical Analysis
All experimental data were expressed as mean ± SEM and
statistically assessed by one-way analysis of variance (ANOVA).
The differences between measurements were analyzed using
student t-test. P-value < 0.01 was considered to be statistically
significant. SPSS software (version 13.0.1; SPSS Inc, Chicago,
IL,USA) and Graph Pad (GraphPad Prism 5.lnk version 5.03)
were used for all statistical analyses.
RESULT
SPP Maintain Mitochondrial Dynamic
Network
Ultra structural analysis of mice skeletal muscle biopsies revealed
an enormous change in mice skeletal muscle mitochondrial
structure in model group compared to normal control group.
Generally Model group showed various abnormalities including
increased number and size of mitochondria, pleomorphism,
compartmentalization, and zigzag cristae as shown in (Figure 1).
This proves use of forced swimming model to induce
mitochondrial dysfunction due to chronic fatigue worked
very well. Whereas, in SPP 200 mg/kg and 400 mg/kg the size
of mitochondria is almost similar to control group while in
positive control (CoQ10) group mitochondrial size is slightly
larger than normal control group but smaller compared to
model group. The other most remarkable abnormality seen
was on internal structure of mitochondria which produced an
appearance of compartmentalization, apparently produced by
branching and fusion of the cristae. In model group almost
all mitochondrion’s lost their normal parallel arrangement
of cristae at the sites of the branching and fusion, some of
mitochondrion’s in SPP 400 mg/kg and positive control (CoQ10)
group also lost some of their parallel arrangement of cristae,
only occasional mitochondria showed compartmentalization.
But in SPP 200 mg/kg the arrangement of cristae was as intact as
normal control group. Moreover the outer and inner membrane
of mitochondria was lysed in forced swimming model group
while it was intact in rest of other group. The results have shown
SPP have protected mitochondrial dysfunction by maintaining
the normal structure and through preserving outer and inner
membrane integrity.
Effect of SPP on ROS
SPP Inhibited Lipid Peroxidation
Forced swimming for 90 min resulted in a significant increase
in lipid peroxidation; as measured by the formation of TBARS
(Figure 2 and Table 1). There is a highly significant increase of
tissue MDA level (P < 0.001) in model group (205.68 nmol/mg
protein) which undergo forced swimming compare to normal
control group (138.84 nmol/mg protein). The current results
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FIGURE 1 | Mitochondrial structure of mice skeletal muscle under electron microscopy. (A,B) control, (C,D) model, (E,F) SPP-200 mg/kg, (G,H)
SPP-400 mg/kg, (I,J) CoQ 10 200 mg/kg at 4.0 K (upper) and 20.0 K (lower) magnification. Scale bar represent 2 um and 200 nm respectively.
FIGURE 2 | (A) Effect of SPP on mice skeletal muscle MDA level. (B) Effect of SPPE on mice skeletal muscle mitochondrial SOD level each bar represent Mean ±
SEM (n=10). Significant at ∗∗∗p-value < 0.001 compared to control; #p-value < 0.05 compared to model.
TABLE 1 | MnSOD and MDA level of mice skeletal muscle.
MDA (nmoles
TBARS/mg protein)
Mn.SOD level
(U/mg protein)
Control 138.84 ± 7.26 293.45 ± 22.45
Model 205.68 ± 8.93∗∗∗ 310.70 ± 20.81
SPP-200 171.38 ± 10.76# 313.42 ± 18.00
SPP-400 179.89 ± 12.30 303.57 ± 17.88
CoQ10 168.07 ± 11.26# 293.87 ± 21.00
Results are expressed as mean ± SEM (n = 10). Significant at ∗∗∗p-value < 0.001
compared to control; #p-value < 0.05 compared to model.
also demonstrated that SPP inhibited lipid peroxidation at
both high and low concentration 171.38 nmol/mg protein and
179.89 nmol/mg protein, respectively (Figure 2 and Table 1)
SPP at 200 mg/kg significantly reduce TBARAS level (P < 0.05)
but SPP at 400 mg/kg was not statistically significant. Positive
control group (CoQ10 200 mg/kg) has also significantly inhibited
lipid peroxidation (168.07 nmol/mg protein) compared to model
group (P < 0.05).
SPP Has No Effect on Mitochondrial SOD Level
Measurement of MnSOD was done to examine the effect SPP on
mitochondrial anti-oxidant level. As seen from the result (Table 1
and Figure 2) forced swimming doesn’t induced any significant
change compared to normal control mice, as well as there is no
significance difference between all treatment groups.
Effect of SPP in Inflammatory Cytokines
Level
SPP Increase Serum TNF-α Level
To elucidate whether forced swimming could increase serum
TNF-α level, and to see the effect SPP on cytokines level
serum TNF-α level was measured as shown in (Figure 3 and
Table 2). Forced swimming of mice for 90 min resulted in
a significant increase in serum TNF-α level of model group
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FIGURE 3 | (A) Effect of SPP on mice serum TNF-α level. (B) Effect of SPP on mice serum IL-6 level. Each bar represent M±SEM (n=10). Significant at
∗∗∗p-value < 0.001 compared control; ###p-value < 0.001, ##p-value < 0.01 compared to model. ∗ indicates significance compared to control.
TABLE 2 | Mice serum TNF-α and IL-6 level.
TNF-α(ng/L) Serum IL-6(pg/ml)
Control 81.07 ± 1.28 13.75 ± 0.42
Model 91.82 ± 1.72∗∗∗ 12.72 ± 0.43
SPP-200 80.42 ± 1.85### 12.79 ± 0.35
SPP-400 84.12 ± 0.96## 14.51 ± 0.35##
CoQ10 77.70 ± 1.33### 15.25 ± 0.55##
Results are expressed as mean ± SEM (n = 10). Significant at ∗∗∗p-value < 0.001
compared control; ###p-value < 0.001, ##p-value < 0.01 compared to model.
(91.82 ng/l) compared to normal control group (81.07 ng/l)
P-value < 0.001. On the other hand, treatment of mice with
SPP 200 and 400 mg/kg significantly reduced serum TNF-
α level 80.42 and 84.12 ng/l, respectively. SPP at lower dose
inhibited serum TNF-α level (P < 0.001) better than SPP
at high dose (P < 0.01) compared to normal control group.
Moreover, positive control mice taking CoQ10 200 mg/kg
have also showed a significant inhibition of TNF-α (P-
value< 0.001).
SPP Increase Serum IL-6 Level
Forced swimming decreased serum IL-6 level (12.72 pg/ml)
compared to normal control group (13.75 pg/ml) but
the difference doesn’t display any statistical significance
(Figure 3 and Table 2). However administration of SPP
at 400 mg/kg significantly increased serum IL-6 level
(14.51 pg/ml) compared to model group (P-value < 0.05)
whereas there was no significant difference compared to
normal control group. Moreover mice which take 200 mg/kg
CoQ10 have also showed a significant increase in serum
IL-6 level (15.25 pg/ml) compared to both model group (P-
value < 0.01) and normal control group (P-value < 0.05).
Although SPP at lower dose (200 mg/kg) increase serum
IL-6 level (12.79) compared to model group, it did not
show any significant difference with both control and model
group.
Effect of SPP on Cell Viability
To determine the effect of SPP on cell viability and cell death, rat
skeletal muscle L6 cell were treated with different concentration
of SPP ranging from 1 mg/ml to 50 ng/ml for 24 h. SPP didn’t
show any significant change in the cell viability of L6 cell ranging
from 100µg/ml to 50 ng/ml (Figure 4). However, it promoted cell
death in dose-dependent manner, at 200 µg/ml (P-value < 0.01)
and above (p-value< 0.001).
DISCUSSION
Several studies have revealed that placenta extract can inhibit
fatigue, aging and many other diseases (Biswas et al., 2001;
Kong et al., 2008; Kong and Park, 2012; Rozanova et al.,
2012). Placenta was also reported to have a possible anti-
oxidant and immune-modulating effect in various biological
systems (Park et al., 2010; Kawakatsu et al., 2013). Peptides
as well have anti-oxidative components, can hinder fatigue
and protect mitochondrial viability and minimize further ROS
generation (Togashi et al., 2002; Wang et al., 2008; Ren
et al., 2011; You et al., 2011).This properties of placenta
and peptide may play an important role on mitochondrial
functioning. Therefore this study examines the effect of SPP
on mitochondria during chronic fatigue induced by forced
swimming.
Mitochondria are the primary controllers of cellular
metabolism and form a reticular network within mammalian
skeletal muscle (Brookes et al., 2004; Pieczenik and Neustadt,
2007; Neustadt and Pieczenik, 2008). Hence defect in
mitochondrial membrane and the general structure will
cause mitochondrial dysfunction resulting fatigue seen in
chronic fatigue patients (Russell et al., 2014). The current finding
also elucidated forced swimming can cause a massive damage in
both inner and outer mitochondrial membranes of mice skeletal
muscle triggering release of mitochondrial components that
will result necrosis and cell death. However, pretreatment with
SPP prevented skeletal muscle mitochondrial structure from
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FIGURE 4 | Effect of SPP (200 ng/ml-l mg/ml) in L6 cell viability. Each bar represents percentage of cell viability. SPP 200 ng/ml-l mg/ml has significantly
reduced the cell viability. Significant at ∗∗∗p-value < 0.001 and ∗∗p-value < 0.01.
FIGURE 5 | Effect of SPP on mitochondrial functioning during chronic
fatigue. SPP in red color shows inhibitory effect, SPP in blue color shows
promotor effect.
damage; SPP shown to protect mitochondrial dynamic network
by maintaining inner and outer membrane integrity.
Moreover, there is an abundant evidence that elevated
production of ROS increases in exceedingly contracting skeletal
muscle during strenuous exercise due to stress (Malm, 2002; Urso
and Clarkson, 2003; Jammes et al., 2009; Finsterer, 2012). In
addition, animal studies provide convincing evidence that ROS
contribute to muscle fatigue induced by prolonged muscular
contractions (Park et al., 2010; Wang et al., 2010). In this study,
a highly significant increase in skeletal muscle MDA level was
found in fatigue model of forced swimming compare to normal
control group. This elevated level of MDA indicates that there
is a high lipid peroxidation in the cell membrane due to attack
of free radicals. Besides, mitochondrial dysfunction is one of
the main causes of oxidative stress mainly induce as a result of
elevated level of ROS, and the main source of ROS generation is
the mitochondria (Balaban et al., 2005; Pieczenik and Neustadt,
2007; Norheim et al., 2011; Indo et al., 2015). For this
reason forced swimming cause lipid peroxidation by elevating
generation of ROS, that will attack mitochondrial components
resulting damage which in turn will cause more elevated level
of ROS, that will make the mitochondrial dysfunction worse. In
contrast pretreatment of experimental animal with SPP inhibited
increment of skeletal muscle MDA level. Since lesser level
of tissue MDA indicate low lipid peroxidation and low ROS
generation, SPP has inhibited lipid peroxidation which will also
cause lower level of ROS and protect damage to mitochondrial
component.
Fatigue is also related to production of inflammatory
cytokines, immune dysfunction, and cytokine imbalances
(Northoff and Berg, 1991; Cannon and St Pierre, 1998; Suzuki
et al., 2002; Doong et al., 2014; Nijs et al., 2014; Peterson
et al., 2015). Several studies have demonstrated muscle tissue
damage after sternness physical exercise, as well as muscle
damage regardless of the cause will induce an inflammatory
response (Tidball, 1995; Huard et al., 2002; Sugama et al.,
2015). Moreover administration of cytokines to smooth muscle
cells reportedly inhibits mitochondrial respiration causing
mitochondrial dysfunction (Chazotte, 2001). This evidence
suggested that cytokines may affect mitochondrial function
during chronic fatigue. Our finding also supports all the above
idea; forced swimming result a dramatic elevation of serum
TNF-α level. Since mitochondria is the main source of ROS
generation required for TNF-α induced cell death, an abnormal
level of TNF-α has a profound effect on mitochondria causing a
marked and prolonged decrease, on mitochondrial and cellular
bioenergetics (Kim et al., 2010; Babu et al., 2015). TNF-α
generates ROS at the mitochondrial inner membrane, which
may easily result in the progressive destruction of the mtDNA,
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as mtDNA lacks the structural protection of histones and their
repair mechanisms; therefore, they are quite susceptible to
damage due to high level ROS generated by TNF-α resulting
mitochondrial dysfunction during chronic fatigue (Corda et al.,
2001; Suematsu, 2003; Kim et al., 2010). As discussed in the above
literatures, elevation of TNF-α cause generation of ROS that
will attack mitochondrial components resultng mitochondrial
dysfunction, as well as chronic fatigue. Hence, forced swimming
model has profoundly induced mitochondrial dysfunction and
chronic fatigue through triggering elevated level of TNF-α
secretion, whereas, SPP significantly attenuated serum TNF-α
secretion in mice during chronic fatigue. Reduction of TNF-
α due to SPP treatment may also result reduction of ROS
generation in mitochondria, this will allow proper functioning
of mitochondria, that will in turns inhibit progression of fatigue
seen in chronic fatigue.
On the other hand, extreme physical stress displayed promotes
the systemic release of cytokine antagonists and factors that
inhibit cytokine synthesis in order to prevent disturbance of
homeostasis due to systemic inflammation (Suzuki et al., 2002).
Researchers have showed that serum IL-6 level can be increased
during extreme physical stress (Malm, 2002; Finsterer, 2012;
Azizbeigi et al., 2015), but unlike TNF-α its elevation do not to
raise ROS level and not related to muscle damage, rather IL-
6 have a function linked to energy metabolism by activation of
glycogenolysis, it displayed to increase glucose uptake during
stress (Malm, 2002; Ando et al., 2010; Finsterer, 2012). Moreover,
IL-6 has a major role as an anti-inflammatory cytokines; it has
a down-regulatory effect on TNF-α and other proinflammatory
cytokines production. It can block the synthesis and action of
TNF-α (Tackey et al., 2004; Brandt and Pedersen, 2010). However,
IL-6 level did not increase in chronic fatigue patients during
excessive exercise (Jammes et al., 2009). This finding also agreed
with the above literatures, there is no significant change in
serum IL-6 level in forced swimming fatigue animal model. but
treatment of experimental animal with SPP can significantly
increase serum IL-6 level, that may linked to its effect to inhibit
mitochondrial ROS production through suppressing TNF-α
elevation during oxidative stress. In addition exhaustion theory
suggests that during stressed exercise, many energy sources, such
as glucose and liver glycogen, will be exhausted, thus leading to
physical fatigue (Wang et al., 2008). Several reports showed that
through the administration of proteins or peptides can facilitate
recovery from fatigue (Wang et al., 2006; You et al., 2011).Thus,
increment of IL-6 level with SPP may increase glucose up take to
alleviate stresses that occur during chronic fatigue.
CONCLUSION
Generally our finding revealed that forced swimming chronic
fatigue model can cause mitochondrial dysfunction by increasing
TNF-α level as well as attacking mitochondrial component
through ROS induced lipid peroxidation and also by disturbing
mitochondrial dynamic network. Whereas, SPP showed to
protect forced swimming induced mitochondrial dysfunction
and protect damage to mitochondrial component through
preventing ROS and TNF-α generation, by maintaining
mitochondrial dynamic network and by increasing serum IL-6
level, that may linked to its effect to inhibit mitochondrial ROS
and also increase glucose up take to alleviate stress that occur
during chronic fatigue (Figure 5).
All of these findings support mitochondria as new
pharmacological targets for treating chronic fatigue and SPP
may represent a novel therapeutic advantage for preventing
mitochondrial dysfunction in patients with chronic fatigue.
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